Belgium· BE-AMP-SAM178525-00
Crixivan 400 mg
A indinavir product containing indinavir sulfate, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 4 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Indinavir is registered in 4 of 19 countries.
Countries holding a registration under ATC J05AE02 (indinavir), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Indinavir · ATC J05AE02
4 / 19 countries
- Belgiumprice
- Finlandprice
- Spainprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Indinavir Sulfate
- Manufacturer
- Merck Sharp & Dohme
- Country
- Belgium (BE)
- ATC code
- J05AE02
- ATC class
- Indinavir
- Defined daily dose
- 2.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb1294511
- be_apb0745893
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
353 interactions on record for indinavir.
Graded by severity as the source publishes them — 124 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Indinavir · interactions on record
353 records
- 124 severe
- 171 moderate
- 20 minor
- 18 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- BudesonideA07EA06severe
20 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Indinavir in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d8dc6e5-4858-4192-a2a4-45cfec1a5348 GET /v1/drugs/3d8dc6e5-4858-4192-a2a4-45cfec1a5348?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "REVOKED",
"name_en": "Crixivan 400 mg",
"name_fr": "Crixivan 400 mg",
"name_nl": "Crixivan 400 mg",
"amp_code": "SAM178525-00",
"strengths": [
"500.0000",
"500.0000",
"400.0000"
],
"pack_count": 3,
"substances": [
"Indinavir Sulfate",
"Indinavir"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Indinavir",
"authorisation_numbers": [
"EU/1/96/024/004",
"EU/1/96/024/005",
"EU/1/96/024/008"
]
}See everything about indinavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.